Naltrexone fails to increase pain affect in response to inflammatory pain in a novel escape/avoidance paradigm

Physiology and Behavior

Volumn 98, Issue 3, 2009, Pages 263-267

  Uhelski, Megan L ^a   Fuchs, Perry N ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Carrageenan; Inflammatory pain; Mechanical hypersensitivity; Morphine; MPWT; Naloxone; Naltrexone; Opioid antagonist; Place Escape Avoidance Paradigm

Indexed keywords

MORPHINE; NALTREXONE;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; ESCAPE BEHAVIOR; INFLAMMATION; MALE; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SENSORY EVALUATION;

ANIMALS; AVOIDANCE LEARNING; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INFLAMMATION; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68049089776     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.05.019     Document Type: Article

References (45)

1. Volavka J., James B., Reker D., Pollock V., and Cho D. Electroencephalo-graphic and other effects of naloxone in normal men. Life Sci 25 (1979) 1267-1272
2. Dayas C.V., Liu X., Simms J.A., and Weiss F. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol Psychiatry 61 8 (2007) 979-989
3. Kariv R., Tiomny E., Greshpon R., Waisman G., and Halpern Z. Low-dose naltrexone for the treatment of irritable bowel syndrome. Am J Gastroenterol 98 9 (2003) S268
4. Berkson B.M., Rubin D.M., and Berkson A.J. Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone. Integr Cancer Ther 6 3 (2007) 293-296
5. Smith J.P., Stock H., Bingaman S., Mauger D., Rogosnitzky M., and Zagon I.S. Low dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol 102 (2007) 820-828
6. Agrawal Y.P. Low dose naltrexone therapy in multiple sclerosis. Med Hypotheses 64 (2005) 721-724
7. Woolf C.J. Intracerebral naloxone and the reaction to thermal noxious stimulation in the rat. Brain Res 190 2 (1980) 578-583
8. France C.R., al'Absi M., Ring C., France J.L., Harju A., and Wittmers L.E. Nociceptive flexion reflex and pain rating responses during endogenous opioid blockade with naltrexone in healthy young adults. Biol Psychol 75 1 (2007) 95-100
9. Robertson L.J., Hammond G.R., and Drummond P.D. The effect of subcutaneous naloxone on experimentally induced pain. J Pain 9 1 (2008) 79-87
10. Kamei J., Kawashima N., and Kasuya Y. Naloxone-induced analgesia in diabetic mice. Eur J Pharmacol 210 (1992) 339-341
11. Kamei J., Kawashima N., and Kasuya Y. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors. Brain Res 592 (1992) 101-105
12. Ueda H., Fukushima N., Kitao T., Ge M., and Takagi H. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci Lett 65 (1986) 247-252
13. Gaumond I., Spooner M.F., and Marchand S. Sex differences in opioid-mediated pain inhibitory mechanisms during the interphase in the formalin test. Neuroscience 146 1 (2007) 366-374
14. Foo H., and Westbrook R.F. Naloxone-induced hypoalgesia: evidence from the formalin test. Pharmacol Biochem Behav 45 (1993) 501-505
15. Choi S., Han K., Lee H., Han E., and Suh H. Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test. Pharmacol Biochem Behav 75 (2003) 447-457
16. LaGraize S.C., LaBuda C.J., Rutledge M.A., Jackson R.L., and Fuchs P.N. Differential effect of anterior cingulate cortex lesion on mechanical hyperalgesia and escape/avoidance behavior in an animal model of neuropathic pain. Exp Neurol 188 (2004) 139-148
17. Vogt B.A., and Sikes R.W. The medial pain system, cingulate cortex, and parallel processing of nociceptive information. Prog Brain Res 122 (2000) 223-235
18. Johansen J.P., Fields H.L., and Manning B.H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 98 14 (2001) 8077-8082
19. Matthies B., and Franklin K. Formalin pain is expressed in decerebrate rats but not attenuated by morphine. Pain 51 2 (1992) 199-206
20. Donahue R.R., LaGraize S.C., and Fuchs P.N. Electrolytic lesion of the anterior cingulate cortex decreases inflammatory, but not neuropathic nociceptive behavior in rats. Brain Res 897 (2001) 131-138
21. Vaccarino A.L., Tasker R.A.R., and Melzack R. Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine. Pain 36 (1989) 103-109
22. Vaccarino A.L., Plamondon H., and Melzack R. Analgesic and aversive effects of naloxone in BALB/c mice. Exp Neurobiol 117 (1992) 216-218
23. LaBuda C.J., and Fuchs P.N. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp Neurol 163 (2000) 490-494
24. LaBuda C.J., and Fuchs P.N. Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain. Neurosci Lett 290 2 (2000) 137-140
25. LaGraize S.C., Borzan J., Peng Y.B., and Fuchs P.N. Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system. Exp Neurol 197 (2006) 22-30
26. DeRosset S.E., and Holtzman S.G. Effects of naloxone and diprenorphine on spontaneous activity in rats and mice. Pharmacol Biochem Behav 17 2 (1982) 347-351
27. Terner J.M., Barrett A.C., Lomas L.M., Negus S.S., and Picker M.J. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains. Pain 122 (2006) 90-101
28. Bianchi M., and Panerai A.E. Naloxone-induced analgesia: involvement of κ-opioid receptors. Pharmacol Biochem Behav 46 (1993) 145-148
29. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 109 (1983) 110
30. Winter C.A., Risley E.A., and Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111 (1962) 544-547
31. Morris C.J. Carrageenan-induced paw edema in the rat and mouse. In: Winyard P.G., and Willoughby D.A. (Eds). Methods in molecular biology (series). Inflammation Protocols vol. 225 (2008) 115-121
32. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20 (1980) 441-462
33. Sawynok J., Pinsky C., and LaBella F.S. Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25 (1979) 1621-1632
34. Carden S.E., and Hofer M.A. Isolation-induced vocalization in Wistar pups is not increased by naltrexone. Physiol Behav 49 6 (1991) 1279-1282
35. Goodwin G.A., Molina V.A., and Spear L.P. Repeated exposure of rat pups to isolation attenuates isolation-induced ultrasonic vocalization rates: reversal with naltrexone. Dev Psychobiol 27 1 (1994) 53-64
36. Dym C.T., Pinhas A., Ginzberg M., Kest B., and Bodnar R.J. Genetic variance contributes to naltrexone-induced inhibition of sucrose intake in inbred and outbred mouse strains. Brain Res 1135 1 (2007) 136-145
37. Helmsetter F.J., and Landeira-Fernandez J. Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray. Brain Res 537 (1990) 88-92
38. Fanselow M.S. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress-analgesia. Ann N Y Acad Sci 467 (1986) 40-54
39. Omrani A., Ghadami M.R., Fathi N., Tahmasian M., Fathollahi Y., and Touhidi A. Naloxone improves impairment of spatial performance induced by pentylenetetrazol kindling in rats. Neuroscience 145 3 (2007) 824-831
40. Rodefer J.S., and Nguyen T.N. Naltrexone reverses age-induced cognitive deficits in rats. Neurobiol Aging 29 2 (2008) 309-313
41. Prow N.A., and Irani D.N. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol 205 2 (2007) 461-470
42. 2 adrenoceptor blockade on naloxone-induced antinociception. Psychopharmacol 113 (1994) 527-533
43. Greeley J.D., Le A.D., Poulos C.X., and Cappell H. "Paradoxical" analgesia induced by naloxone and naltrexone. Psychopharmacology (Berl) 96 1 (1988) 36-39
44. Franklin K.B., and Abbott F.V. Pentobarbital, diazepam, and ethanol abolish the interphase diminution of pain in the formalin test: evidence for pain modulation by GABA-A receptors. Pharmacol Biochem Behav 46 3 (1993) 661-666
45. Gewiss M., Marley R.J., Thorndike E.B., Goldberg S.R., and Schindler C.W. GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats. Pharmacol Biochem Behav 49 3 (1994) 589-597